IRIS
FERRAROTTI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.643
AS - Asia 2.234
EU - Europa 1.529
SA - Sud America 345
AF - Africa 94
OC - Oceania 1
Totale 6.846
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.572
CN - Cina 874
SG - Singapore 538
VN - Vietnam 305
HK - Hong Kong 288
BR - Brasile 262
IE - Irlanda 260
RU - Federazione Russa 233
DE - Germania 199
IT - Italia 187
FR - Francia 129
FI - Finlandia 120
GB - Regno Unito 114
UA - Ucraina 102
ZA - Sudafrica 59
SE - Svezia 57
IN - India 55
CA - Canada 44
BD - Bangladesh 33
AR - Argentina 28
BE - Belgio 19
IQ - Iraq 19
NL - Olanda 19
PL - Polonia 18
AT - Austria 17
EC - Ecuador 16
MX - Messico 16
TR - Turchia 15
PH - Filippine 13
CZ - Repubblica Ceca 12
ES - Italia 11
JP - Giappone 11
PK - Pakistan 11
VE - Venezuela 10
CO - Colombia 9
ID - Indonesia 9
UZ - Uzbekistan 9
MA - Marocco 8
SA - Arabia Saudita 8
CH - Svizzera 7
CL - Cile 7
LT - Lituania 7
PY - Paraguay 6
TN - Tunisia 6
JO - Giordania 5
KE - Kenya 5
LB - Libano 5
MY - Malesia 5
DK - Danimarca 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
ET - Etiopia 3
IL - Israele 3
MU - Mauritius 3
NP - Nepal 3
QA - Qatar 3
BB - Barbados 2
BY - Bielorussia 2
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
KR - Corea 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 6.845
Salva come PNG Salva come JPEG
Città #
San Jose 375
Singapore 276
Hong Kong 273
Dublin 260
Ashburn 256
Chandler 244
Dallas 213
Beijing 210
Nanjing 151
Jacksonville 100
Ho Chi Minh City 98
Boardman 88
Lauterbourg 84
Ann Arbor 78
Los Angeles 76
Hanoi 74
Redondo Beach 63
Munich 61
Helsinki 60
New York 59
Council Bluffs 55
Johannesburg 48
Lawrence 45
Princeton 45
Medford 44
Moscow 42
Nanchang 42
Dearborn 40
Shanghai 39
Wilmington 34
Shenyang 32
São Paulo 32
Changsha 31
Buffalo 28
Houston 28
Turku 24
Jiaxing 23
Orem 23
Hebei 22
Frankfurt am Main 21
Brussels 19
Da Nang 19
Milan 19
Toronto 19
Pavia 18
Tianjin 18
Nuremberg 17
Vinnytsia 17
Phoenix 16
Rome 16
The Dalles 16
Amsterdam 15
Brooklyn 15
Falkenstein 15
Hangzhou 15
Montesilvano Marina 15
Santa Clara 15
Chongqing 14
London 14
Piemonte 14
Warsaw 14
Woodbridge 14
Chicago 13
Haiphong 12
Kunming 11
Stockholm 11
Tokyo 11
Denver 10
Montreal 10
Redwood City 10
Washington 10
Atlanta 9
Chennai 9
Vienna 9
Guangzhou 8
Norwalk 8
Poplar 8
Tashkent 8
Ankara 7
Basingstoke 7
Des Moines 7
Jinan 7
Turin 7
Baghdad 6
Biên Hòa 6
Düsseldorf 6
Fairfield 6
Hefei 6
Hyderabad 6
Hải Dương 6
New Delhi 6
Rio de Janeiro 6
Seattle 6
Zhengzhou 6
Belo Horizonte 5
Bologna 5
Brasília 5
Caracas 5
Charlotte 5
Fortaleza 5
Totale 4.439
Salva come PNG Salva come JPEG
Nome #
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 180
Lyosecretome for use in the treatment of autoimmune diseases 140
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 139
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 137
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 136
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 136
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies 134
Expression of receptor for advanced glycation end products in sarcoid granulomas. 118
A regulatory SNP in the Promoter Region of the RAGE Gene 117
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 117
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 117
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 114
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 113
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 111
Identification and characterisation of eight novel SERPINA1 null mutations. 111
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 108
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 107
Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD 107
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 106
Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease 102
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 101
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. 101
Alpha-1 antitrypsin deficiency: From the lung to the heart? 99
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 98
α₁-Antitrypsin level and pheno/genotypes 97
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 97
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 95
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 94
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 91
COPD: no gene left unturned 89
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 88
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 87
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. 86
An Italian expert consensus on the management of alpha1-antitrypsin deficiency: a comprehensive set of algorithms 84
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 84
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? 84
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 83
The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency 82
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 81
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 80
Molecular diagnosis of alpha1-antitrypsin deficiency: A new method based on Luminex technology 78
Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency 76
The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization. 74
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review 70
Update on α1-antitrypsin deficiency 70
Immune Activation in alpha(1)-Antitrypsin-Deficiency Emphysema Beyond the Protease-Antiprotease Paradigm 70
Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency 70
Practical dietary advices for subjects with alpha-1 antitrypsin deficiency 69
COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale 69
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. 69
Comparison of different algorithms in laboratory diagnosis of alpha1-antitrypsin deficiency 67
Kruppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. 65
Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency. 65
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer 63
Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: Enough is enough 63
Improving the diagnosis of AATD with aid of serum protein electrophoresis: A prospective, multicentre, validation study 61
Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency 61
The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints 61
α1-Antitrypsin deficiency. 60
Recommendations for the measurement of the most important plasma proteins 59
Place of genotyping and phenotype in addition to the assay of serum α -1 antitrypsin 58
Alpha-1 antitrypsin deficiency is significantly associated with atopy in asthmatic patients 58
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 57
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. 55
Sanger and Next-Generation Sequencing of AAT 54
Quantification of circulating alpha-1-antitrypsin polymers associated with different SERPINA1 genotypes 54
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 54
Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. 54
Alpha1-antitrypsin deficiency in Greece: Focus on rare variants 53
Clinical manifestations in patients with PI*MMMalton genotypes. A matter still unsolved in alpha-1 antitrypsin deficiency 51
Complement receptor 1 gene polymorphisms in sarcoidosis. 49
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use 48
Air Trapping Is Associated with Heterozygosity for Alpha-1 Antitrypsin Mutations in Patients with Asthma 48
How can we improve the detection of Alpha1-antitrypsin deficiency? 47
SERPINA1 gene variants in individuals from the general population with reduced ?1-antitrypsin concentrations 43
Effect of α1 antitrypsin deficiency on lung volume decline in severe asthmatic patients undergoing biologic therapy 41
Protocol for the earco registry: A pan-european observational study in patients with α1-antitrypsin deficiency 40
Long-term effect of α1-antitrypsin augmentation therapy on the decline of fev1 in deficient patients: An analysis of the air database 38
Alpha-1 antitrypsin screening in a selected cohort of patients affected by chronic pulmonary diseases in Naples, Italy 38
Transplant with MZ genotype liver: what is the clinical pulmonary picture after 30 years? a case report and review of the literature 38
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 38
What is the knowledge on alpha-1 antitrypsin deficiency among Italian pulmonologists? 36
The importance of n186 in the alpha-1-antitrypsin shutter region is revealed by the novel bologna deficiency variant 35
Phenotypic Expression of Respiratory Diseases and Tailored Treatment in Patients with Intermediate Alpha-1 Antitrypsin Deficiency: Evidence from a Retrospective Analysis of a Selected Cohort of Patients 33
New patient-centric approaches to the management of alpha-1 antitrypsin deficiency 33
Diagnosis and treatment of pulmonarydisease in alfa-1-antitrypsin deficiency: A statement of European Respiratory Society 32
Research priorities in α1-antitrypsin deficiency: Results of a patients’ and healthcare providers’ international survey from the earco clinical research collaboration 31
Investigating the Link between Alpha-1 Antitrypsin Deficiency and Abdominal Aortic Aneurysms 29
Electrophoretic α1-globulin for screening of α1-antitrypsin deficient variants 28
Alpha-1 antitrypsin deficiency-associated liver disease: A review focusing on new assessment tools and therapies 26
PI*ZQ0Attikon genotype discovery in severe alpha-1 antitrypsin deficiency 24
The phenotypic state of bi allelic SERPINA1 Q0 variants in alpha-1 antitrypsin deficiency 22
Performance of enhanced liver fibrosis test and indirect serum fibrosis markers for exclusion of advanced liver fibrosis in alpha-1 antitrypsin deficiency 11
Totale 6.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.689
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 0 0 24
2021/2022199 6 2 4 5 1 2 5 16 13 4 28 113
2022/2023712 85 49 6 44 82 68 3 30 308 7 20 10
2023/2024395 26 75 16 10 35 98 11 20 2 53 27 22
2024/20251.476 20 71 76 90 30 134 57 80 329 70 185 334
2025/20263.147 235 200 322 348 379 158 670 118 317 231 116 53
Totale 6.947